Clinical and Experimental Dermatology最新文献

筛选
英文 中文
Interpretation of ferritin concentrations in the dermatology clinic. 皮肤科门诊中铁蛋白浓度的解读。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-27 DOI: 10.1093/ced/llae342
Callum D Verran, Madeleine G Alexander, Alexa R Shipman, Kate E Shipman
{"title":"Interpretation of ferritin concentrations in the dermatology clinic.","authors":"Callum D Verran, Madeleine G Alexander, Alexa R Shipman, Kate E Shipman","doi":"10.1093/ced/llae342","DOIUrl":"10.1093/ced/llae342","url":null,"abstract":"<p><p>Ferritin measurement is a common laboratory test in dermatology. Ferritin is a marker of iron storage in the human body but can also be -elevated in inflammatory states. Therefore, changes in ferritin are nonspecific, and correlation of specific clinical findings and risk factors with ferritin concentration and other biomarkers, e.g. iron studies or C-reactive protein tests, is recommended. This article discusses iron metabolism and the indications for ferritin measurement in dermatology and how to interpret the laboratory results.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"307-313"},"PeriodicalIF":3.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of atenolol vs. propranolol for treatment of infantile haemangioma: a narrative review. 阿替洛尔与普萘洛尔治疗婴儿血管瘤的疗效和安全性:叙述性综述。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-27 DOI: 10.1093/ced/llae401
Michelle Shi, Orli Wargon, Artiene Tatian
{"title":"Efficacy and safety of atenolol vs. propranolol for treatment of infantile haemangioma: a narrative review.","authors":"Michelle Shi, Orli Wargon, Artiene Tatian","doi":"10.1093/ced/llae401","DOIUrl":"10.1093/ced/llae401","url":null,"abstract":"<p><p>Infantile haemangioma (IH) remains the most common benign vascular tumour in childhood. Although most IH can be managed conservatively, a proportion of these lesions can cause disfigurement, ulceration or functional impairment, requiring prompt intervention. Propranolol, a lipophilic nonselective beta blocker, has been regarded as first-line therapy, following a serendipitous discovery of its use for IH in 2008. Although efficacious, it has been associated with adverse effects such as hypoglycaemia, bronchospasm, sleep disturbances and agitation in infant trials. Atenolol, a hydrophilic beta-1 selective blocker, has demonstrated similar efficacy and potentially greater tolerability, being less likely to cause sleep disturbances given its inability to cross the blood-brain barrier, and a decrease in bronchial reactivity. The purpose of this review is to explore and critique current knowledge about the efficacy and safety of propranolol vs. atenolol in children with an IH. In total, seven studies comparing the two beta blockers were identified in our search. Atenolol appeared to be as efficacious as propranolol and was associated with fewer central nervous system and bronchial-related adverse events. Further research exploring the optimal dosing for atenolol, particularly for ulcerated or syndromic IHs, as well as the incidence and management of rebound growth would be beneficial.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"331-338"},"PeriodicalIF":3.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonablative laser therapy for cutaneous Kaposi sarcoma: a single centre proof-of-concept study of six patients. 治疗皮肤卡波西肉瘤的非烧蚀激光疗法--一项针对六名患者的单中心概念验证研究。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-27 DOI: 10.1093/ced/llae390
Muhammad H Junejo, Brian P Hibler, Leore Levin, Christian Menzer, Abdullah Aleisa, Anthony M Rossi
{"title":"Nonablative laser therapy for cutaneous Kaposi sarcoma: a single centre proof-of-concept study of six patients.","authors":"Muhammad H Junejo, Brian P Hibler, Leore Levin, Christian Menzer, Abdullah Aleisa, Anthony M Rossi","doi":"10.1093/ced/llae390","DOIUrl":"10.1093/ced/llae390","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"455-457"},"PeriodicalIF":3.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation and systemic therapy. 配方和系统疗法专业证书考试案例。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-27 DOI: 10.1093/ced/llae405
Frances Bell, Jenny Nicolopoulos, Con Dolianitis
{"title":"Formulation and systemic therapy.","authors":"Frances Bell, Jenny Nicolopoulos, Con Dolianitis","doi":"10.1093/ced/llae405","DOIUrl":"10.1093/ced/llae405","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"468-470"},"PeriodicalIF":3.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142380142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual impairment in patients with atopic dermatitis. 特应性皮炎患者的性功能障碍。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-27 DOI: 10.1093/ced/llae360
Laurent Misery, Julien Seneschal, Florence Corgibet, Bruno Halioua, Francesca Sampogna, Stéphanie Merhand, Charbel Skayem, Yaron Ben Hayoun, Charles Taieb, Delphine Staumont-Sallé, Khaled Ezzedine, Marie-Aleth Richard
{"title":"Sexual impairment in patients with atopic dermatitis.","authors":"Laurent Misery, Julien Seneschal, Florence Corgibet, Bruno Halioua, Francesca Sampogna, Stéphanie Merhand, Charbel Skayem, Yaron Ben Hayoun, Charles Taieb, Delphine Staumont-Sallé, Khaled Ezzedine, Marie-Aleth Richard","doi":"10.1093/ced/llae360","DOIUrl":"10.1093/ced/llae360","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"422-423"},"PeriodicalIF":3.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Higher odds of squamous cell carcinoma in sexual minority males compared with heterosexual males is mediated by HIV status in a mediation analysis of 13 687 participants. 在对 13,687 名参与者进行的中介分析中,与异性恋男性相比,性少数群体男性罹患鳞状细胞癌的几率更高,而这与 HIV 感染状况有关。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-27 DOI: 10.1093/ced/llae364
Kaya L Curtis, Onajia Stubblefield, Slavina B Goleva, Joshua C Denny, Shari R Lipner
{"title":"Higher odds of squamous cell carcinoma in sexual minority males compared with heterosexual males is mediated by HIV status in a mediation analysis of 13 687 participants.","authors":"Kaya L Curtis, Onajia Stubblefield, Slavina B Goleva, Joshua C Denny, Shari R Lipner","doi":"10.1093/ced/llae364","DOIUrl":"10.1093/ced/llae364","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"425-427"},"PeriodicalIF":3.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11771314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142104918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current wig prescribing practices and financial evaluation in a National Health Service Foundation Trust: lessons learnt and future challenges. 一家 NHS 基金会信托机构目前的假发处方做法和财务评估:经验教训与未来挑战。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-27 DOI: 10.1093/ced/llae261
Hannah E Ross, Xian Hue Ong, Lynn Wilks, Sue Schilling, Matthew Harries, Leila Asfour
{"title":"Current wig prescribing practices and financial evaluation in a National Health Service Foundation Trust: lessons learnt and future challenges.","authors":"Hannah E Ross, Xian Hue Ong, Lynn Wilks, Sue Schilling, Matthew Harries, Leila Asfour","doi":"10.1093/ced/llae261","DOIUrl":"10.1093/ced/llae261","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"420-422"},"PeriodicalIF":3.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141579135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early detection of anal squamous cell carcinoma with the use of high-resolution anoscopy. 利用高分辨率肛门镜早期发现肛门鳞状细胞癌。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-27 DOI: 10.1093/ced/llae362
Muhammad Hyder Junejo, Oluwatobiloba Ifeoluwa Oyebanji, Baihan Wang, Carmelina Cappello, Brenton Wait, Emily Farrow, Mayura Nathan, Julie Bowring, Tamzin Cuming
{"title":"Early detection of anal squamous cell carcinoma with the use of high-resolution anoscopy.","authors":"Muhammad Hyder Junejo, Oluwatobiloba Ifeoluwa Oyebanji, Baihan Wang, Carmelina Cappello, Brenton Wait, Emily Farrow, Mayura Nathan, Julie Bowring, Tamzin Cuming","doi":"10.1093/ced/llae362","DOIUrl":"10.1093/ced/llae362","url":null,"abstract":"<p><p>In the UK, few (12%) anal squamous cell carcinomas (aSCCs) are diagnosed early at stage 1 (T1N0M0). The Homerton Anogenital Neoplasia Service (HANS) is a highly specialized tertiary centre where high-resolution anoscopy (HRA) is performed to diagnose and treat anal intraepithelial neoplasia (AIN), a precursor to cancer. In some cases, aSCC (here defined as anal canal cancers and perianal cancers up to 5 cm from the anal verge) is found on referral for AIN; in others, aSCC may develop during management of AIN. We reviewed aSCC diagnoses at our specialist unit to establish whether HRA offers added value in the early detection of aSCC in a high-risk cohort. A cross-sectional analysis was performed of all primary aSCC diagnoses at HANS between January 2016 and June 2021. Patient records and histopathology and radiology reports were reviewed to define anal cancer stage per TNM classification (AJCC version 8). The results were compared with national anal cancer data published by the Office for National Statistics (AJCC version 8). Fifty-three aSCC diagnoses were made at HANS; 35 (66%) were stage 1 (14 prevalent, 21 incident), 11 (21%) stage 2 (9 prevalent, 2 incident) and 6 (11%) stage 3 (5 prevalent, 1 incident). None were stage 4, and one cancer was unstageable due to further management at another unit. By comparison, 5836 aSCCs were diagnosed in the UK between 2013 and 2017. Of these, 12.0% were stage 1, 22.8% stage 2, 33.0% stage 3 and 8.5% stage 4; 23.8% were unknown or unstageable. There was a statistically significant difference in the proportion of early (i.e. stage 1) HRA-detected cancers between HANS and national statistics (P < 0.001). Our results suggest that surveillance and examination within an HRA programme may lead to the detection of aSCC at an earlier stage, allowing for less morbid treatment and potentially lower mortality.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"395-398"},"PeriodicalIF":3.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142104885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of game-based learning strategies for dermatology and dermoscopy education: a cross-sectional survey of members of the International Dermoscopy Society. 在皮肤病学和皮肤镜教育中使用基于游戏的学习策略:国际皮肤镜学会(IDS)调查的横断面研究。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-27 DOI: 10.1093/ced/llae375
Francisca Donoso, Dominga Peirano, Rosario Agüero, Caterina Longo, Zoe Apalla, Aimilios Lallas, Natalia Jaimes, Cristian Navarrete-Dechent
{"title":"Use of game-based learning strategies for dermatology and dermoscopy education: a cross-sectional survey of members of the International Dermoscopy Society.","authors":"Francisca Donoso, Dominga Peirano, Rosario Agüero, Caterina Longo, Zoe Apalla, Aimilios Lallas, Natalia Jaimes, Cristian Navarrete-Dechent","doi":"10.1093/ced/llae375","DOIUrl":"10.1093/ced/llae375","url":null,"abstract":"<p><strong>Background: </strong>Dermoscopy is a valuable tool in the diagnosis of various skin conditions. It increases sensitivity and specificity in skin cancer diagnosis, as well as in infectious, inflammatory and hair diseases. However, mastering the intricacies of dermoscopy can be challenging. In this context, innovative educational methods are sought, including game-based learning (GBL) strategies.</p><p><strong>Objectives: </strong>To describe current perceptions, knowledge and use of GBL strategies in dermoscopy education, and identify strengths and challenges to enhance their use.</p><p><strong>Methods: </strong>A web-based cross-sectional survey with 25 questions was distributed to members of the International Dermoscopy Society -between October 2022 and April 2023. Responses were collected and analysed using frequency analysis and graphical representation.</p><p><strong>Results: </strong>In total, 801 responses were received. Of these, 46.6% of respondents were unfamiliar with gamification and serious games. Among those acquainted with these concepts, 56.3% reported using GBL strategies for education. Younger participants were more likely to use GBL strategies (P = 0.02). Participants familiar with GBL believed it enhanced medical education (78.5%) but should not entirely replace traditional teaching methods (96.0%). For dermoscopy education specifically, 22.1% of respondents had used GBL strategies, with Kahoot! (35.5%) and YOUdermoscopy (24.1%) being the most commonly used platforms. Respondents found gaming strategies to be fun (95.5%), motivating (91.0%) and valuable for e-learning (94.4%).</p><p><strong>Conclusions: </strong>Results from this survey demonstrate a favourable perception of GBL strategies in dermatology education, including dermoscopy. While there are ongoing challenges in validation, GBL strategies are promising and valuable tools that can aid the learning and teaching experience. Addressing implementation barriers and validating existing games could optimize the impact of GBL on dermatology education.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"365-371"},"PeriodicalIF":3.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142281279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monoclonal antibodies for the management of cutaneous lupus erythematosus: an update on the current treatment landscape. 治疗皮肤红斑狼疮的单克隆抗体:当前治疗格局的最新进展。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-27 DOI: 10.1093/ced/llae374
Alexander J Jafari, Christina McGee, Natasha Klimas, Adelaide A Hebert
{"title":"Monoclonal antibodies for the management of cutaneous lupus erythematosus: an update on the current treatment landscape.","authors":"Alexander J Jafari, Christina McGee, Natasha Klimas, Adelaide A Hebert","doi":"10.1093/ced/llae374","DOIUrl":"10.1093/ced/llae374","url":null,"abstract":"<p><p>Cutaneous lupus erythematosus (CLE) is a complex autoimmune disease often characterized by a multitude of skin findings. CLE is generally classified into three main categories: acute CLE, subacute CLE and chronic CLE. The current therapeutic guidelines for CLE include counselling patients on general measures and medication regimens. Treatment options include optimized photoprotection, avoidance of environmental triggers, corticosteroids, topical and systemic immunomodulators, and antimalarials. To date, no biologic medications (i.e. monoclonal antibodies, mAbs) are approved for CLE. The first mAb for the treatment of both systemic lupus erythematosus (SLE) and active lupus nephritis was belimumab, and was approved for these diseases in 2011 and 2020, respectively. Belimumab is a specific inhibitor of B-lymphocyte stimulator. Anifrolumab, a type I interferon receptor antagonist, was approved in 2021 for SLE. Other mAbs with different targets, including a novel biologic that inhibits blood dendritic cell antigen 2, are currently under investigation for CLE. This review will describe the general treatment landscape for CLE. Selected studies related to these various mAbs will be discussed, as well as their safety profiles and efficacies demonstrated in clinical trials. Biologic medications can potentially augment the number of treatment options for patients living with CLE.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"314-322"},"PeriodicalIF":3.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信